Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Schiff

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Annals of the Rheumatic Diseases|October 14, 2006
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006D E Furst, F C Breedveld, J R Kalden, et al.
The New England Journal of Medicine|November 30, 2000
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritisJ M Bathon, R W Martin, R M Fleischmann, et al.
Annals of the Rheumatic Diseases|November 21, 2007
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007D E Furst, F C Breedveld, J R Kalden, et al.
Arthritis and Rheumatism|July 13, 2002
Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomesMark C Genovese, Joan M Bathon, Richard W Martin, et al.
Rheumatology (Oxford, England)|March 21, 2000
Microemulsion formulation of cyclosporin (Sandimmun Neoral) vs Sandimmun: comparative safety, tolerability and efficacy in severe active rheumatoid arthritis. On behalf of the OLR 302 Study GroupD E Yocum, S Allard, S B Cohen, et al.
Arthritis and Rheumatism|October 31, 2009
Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trialEva C Koffeman, Mark Genovese, Diane Amox, et al.
Annals of Internal Medicine|March 13, 1999
Etanercept therapy in rheumatoid arthritis. A randomized, controlled trialL W Moreland, M H Schiff, S W Baumgartner, et al.
Annals of the Rheumatic Diseases|December 17, 2008
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008D E Furst, E C Keystone, B Kirkham, et al.
Annals of the Rheumatic Diseases|December 10, 2009
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009D E Furst, E C Keystone, R Fleischmann, et al.
Arthritis and Rheumatism|September 29, 2004
Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosusMichelle A Petri, Philip J Mease, Joan T Merrill, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Annals of the Rheumatic Diseases|October 14, 2006
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006D E Furst, F C Breedveld, J R Kalden, et al.
The New England Journal of Medicine|November 30, 2000
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritisJ M Bathon, R W Martin, R M Fleischmann, et al.
Annals of the Rheumatic Diseases|November 21, 2007
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007D E Furst, F C Breedveld, J R Kalden, et al.
Arthritis and Rheumatism|July 13, 2002
Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomesMark C Genovese, Joan M Bathon, Richard W Martin, et al.
Rheumatology (Oxford, England)|March 21, 2000
Microemulsion formulation of cyclosporin (Sandimmun Neoral) vs Sandimmun: comparative safety, tolerability and efficacy in severe active rheumatoid arthritis. On behalf of the OLR 302 Study GroupD E Yocum, S Allard, S B Cohen, et al.
Arthritis and Rheumatism|October 31, 2009
Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trialEva C Koffeman, Mark Genovese, Diane Amox, et al.
Annals of Internal Medicine|March 13, 1999
Etanercept therapy in rheumatoid arthritis. A randomized, controlled trialL W Moreland, M H Schiff, S W Baumgartner, et al.
Annals of the Rheumatic Diseases|December 17, 2008
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008D E Furst, E C Keystone, B Kirkham, et al.
Annals of the Rheumatic Diseases|December 10, 2009
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009D E Furst, E C Keystone, R Fleischmann, et al.
Arthritis and Rheumatism|September 29, 2004
Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosusMichelle A Petri, Philip J Mease, Joan T Merrill, et al.
Pageof 8